HIV Among Drug Users at Beth Israel Medical Center, New York City, the First 25 Years

REFERENCES

• Anderson, W. (1991). The New York needle trial: The politics of public health in the age of AIDS. American Journal of Public Health, 81, 1506–1517.
   PubMed Web of Science ®Google Scholar
• Bennani, Y., Forgione, L., & Torian, L. (2007). HIV incidence estimates using STARHS over the first four and one-half years of named HIV reporting in NYC, 2000–2004. Paper presented at the 14th Conference on Retroviruses & Opportunistic Infections, Los Angeles, CA.
   Google Scholar
• Casriel, C., Des Jarlais, D. C., Rodriguez, R., Friedman, S. R., Stepherson, B., & Khuri, E. (1990). Working with heroin sniffers: Clinical issues in preventing drug injection. Journal of Substance Abuse Treatment, 7, 1–10.
   PubMed Web of Science ®Google Scholar
• Casriel, C., Rockwell, R., & Stepherson, B. (1988). Heroin sniffers: Between two worlds. Journal of Psychoactive Drugs, 20, 437–440.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (1981). Pneumocystis pneumonia—Los Angeles. Morbidity and Mortality Weekly Report, 30, 250–252.
   PubMedGoogle Scholar
• Craib, K., Spittal, C., Wood, E., Laliberte, N., Hogg, R., Li, K., (2003). Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. Canadian Medical Association Journal, 168, 19–24.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, A., Hagan, H., McKnight, C., Perlman, D., & Friedman, S. R. (2009). Persistence and change in disparities in HIV infection among injecting drug users in New York City after large-scale syringe exchange. American Journal of Public Health, 99(Suppl. 2), S445–S451.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D., & Friedman, S. R. (2009). Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug and Alcohol Dependence, 101, 88–91.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., Perlis, T., Hagan, H., Abdul-Quader, A., Heckathorn, D., (2007). Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City: A new stage in a very large HIV epidemic. AIDS, 21, 231–235.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., Perlis, T., Hagan, H., Heckathorn, D., McKnight, C., (2007). The transition from injection to non-injection drug use: Long-term outcomes among heroin and cocaine users in New York City. Addiction, 102, 778–785.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Hagan, H., Friedman, S. R., Friedmann, P., Goldberg, D., Frischer, M., (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association, 274, 1226–1231.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Casriel, C., Friedman, S. R., & Rosenblum, A. (1992). AIDS and the transition to illicit drug injection: Results of a randomized trial prevention program. British Journal of Addiction, 87, 493–498.
   PubMedGoogle Scholar
• Des Jarlais, D. C., Choopanya, K., Vanichseni, S., Plangsringarm, K., Sonchai, W., Carballo, M., (1994). AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok. American Journal of Public Health, 84, 452–455.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Friedman, S. R., & Hopkins, W. (1985). Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Annals of Internal Medicine, 103, 755–759.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Friedman, S. R., Novick, D. M., Sotheran, J. L., Thomas, P., Yancovitz, S., (1989). HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. Journal of the American Medical Association, 261, 1008–1012.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., & Hopkins, W. (1985). “Free” needles for intravenous drug users at risk for AIDS: Current developments in New York City. New England Journal of Medicine, 313, 1476.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Marmor, M., Friedmann, P., Aviles, E., Deren, S., Torian, L. V., (2000). HIV incidence among injecting drug users in New York City, 1992–1997: Evidence for a declining epidemic. American Journal of Public Health, 90, 352–359.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Arasteh, K., Hagan, H., Milliken, J., Braine, N., (2004). “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. Journal of Acquired Immune Deficiency Syndromes, 35, 158–166.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Beatrice, S., Milliken, J., (2005). HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services. American Journal of Public Health, 95, 1439–1444.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Friedman, S. R., Chapman, T., Kwok, J., Rockwell, R., (2000). Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990–1997. American Journal of Public Health, 90, 1112–1116.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Friedman, S. R., Deren, S., Chapman, T. F., Sotheran, J. L., (1998). Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996. American Journal of Public Health, 88, 1801–1806.
   PubMed Web of Science ®Google Scholar
• Diaz, T., Des Jarlais, D. C., Vlahov, D., Perlis, T. E., Edwards, V., Freidman, S. R., (2001). Factors associated with prevalent hepatitis C virus infection: Differences among young adult injection drug users in lower and upper Manhattan, New York City. American Journal of Public Health, 91, 23–30.
   PubMed Web of Science ®Google Scholar
• Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B., Word, C., Serrano, Y., (1994). Intersecting epidemics: Crack cocaine use and HIV infection among inner-city young adults. New England Journal of Medicine, 331, 1422–1427.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Jose, B., Deren, S., Des Jarlais, D. C., Neaigus, A., & National AIDS Consortium. (1995). Risk factors for HIV seroconversion among out-of-treatment drug injectors in high and low-seroprevalence cities. American Journal of Epidemiology, 142, 864–874.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Quimby, R. E., Sufian, M., Abdul-Quader, A., & Des Jarlais, D. C. (1988). Racial aspects of the AIDS epidemic. California Sociologist, Winter–Summer, 55–68.
   Google Scholar
• Friedman, S. R., Sotheran, J. L., Abdul-Quader, A., Primm, B. J., Des Jarlais, D. C., Kleinman, P., (1987). The AIDS epidemic among Blacks and Hispanics. Milbank Quarterly, 65, 455–499.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Sufian, M., & Des Jarlais, D. C. (1990). The AIDS epidemic among latino intravenous drug users. In R. Glick & J. Moore (Eds.), Drugs in Hispanic communities (pp. 45–54). New Brunswick, NJ: Rutgers University Press.
   Google Scholar
• Friedman, S. R., Tempalski, B., Cooper, H., Perlis, T., Keem, M., Friedman, R., (2004). Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. Journal of Urban Health, 81, 377–400.
   PubMed Web of Science ®Google Scholar
• Hogg, R., Strathdee, S., Kerr, T., Wood, E., & Remis, R. (2005). HIV prevalence among Aboriginal British Columbians. Harm Reducion Journal, 2, 26–31.
   PubMedGoogle Scholar
• Department of Health and Mental Hygiene. (2006). New York City health. New York: Author.
   Google Scholar
• Kaplan, E. H., & Heimer, R. (1992). A model-based estimate of HIV infectivity via needle sharing. Journal of Acquired Immune Deficiency Syndromes, 5, 1116–1118.
   PubMed Web of Science ®Google Scholar
• Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., & Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet, 357, 1397–1401.
   PubMed Web of Science ®Google Scholar
• Li, W., Kennedy, J., Kelley, D., Sun, Y., Maduro, G., Curry, A., (2008). Summary of vital statistics 2007: The city of New York. New York: New York City Department of Health and Mental Hygiene, Statistical Analysis and Reporting Unit and Research and Surveillance Unit of the Bureau of Vital Statistics.
   Google Scholar
• Marmor, M., Des Jarlais, D. C., Cohen, H., Friedman, S. R., Beatrice, S. T., Dubin, N., (1987). Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS, 1, 39–44.
   PubMed Web of Science ®Google Scholar
• Marmor, M., Titus, S., Wolfe, H., Kransinski, K., Maslansky, R., Simberkoff, M., (1994). Preparation for AIDS vaccine trials: Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs. AIDS Research and Human Retroviruses, 10, S207–S213.
   PubMed Web of Science ®Google Scholar
• Maslow, C. B., Friedman, S. R., Perlis, T. E., Rockwell, R., & Des Jarlais, D. C. (2002). Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990–1999. American Journal of Public Health, 92, 382–384.
   PubMed Web of Science ®Google Scholar
• Nash, D., Bennani, Y., Ramaswamy, C., & Torian, L. V. (2005). Estimates of HIV incidence among persons testing for HIV using the sensitive/less sensitive enzyme immunoassay, New York City, 2001. Journal of Acquired Immune Deficiency Syndromes, 39, 102–111.
   PubMed Web of Science ®Google Scholar
• National Commission on AIDS. (1991). Full report: The twin epidemics of substance use and HIV. Washington, DC: Dogwood Center.
   Google Scholar
• Neaigus, A., Atillasoy, A., Friedman, S. R., Andrade, X., Miller, M., Ildefonso, G., (1998). Trends in the non-injected use of heroin and factors associated with the transition to injecting. In J. Inciardi & L. D. Harrison (Eds.), Heroin in the age of crack cocaine (pp. 131–159). Thousand Oaks, CA: Sage.
   Google Scholar
• Neaigus, A., Gyarmathy, V., Miller, M., Frajzyngier, V., Friedman, S. R., & Des Jarlais, D. C. (2006). Transitions to injecting drug use among noninjecting heroin users: Social network influence and individual susceptibility. Journal of Acquired Immune Deficiency Syndromes, 41, 493–503.
   PubMed Web of Science ®Google Scholar
• Neaigus, A., Sufian, M., Friedman, S. R., Goldsmith, D., Stepherson, B., Mota, P., (1990). Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Education and Prevention, 2, 253–271.
   PubMedGoogle Scholar
• Nelson, K. E., Vlahov, D., Solomon, L., Cohn, S., & Munoz, A. (1995). Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD. Archives of Internal Medicine, 155, 1305–1311.
   PubMedGoogle Scholar
• Novick, D. M., Trigg, H. L., Des Jarlais, D. C., Friedman, S. R., Vlahov, D., & Kreek, M. J. (1989). Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. Journal of Medical Virology, 29, 181–185.
   PubMed Web of Science ®Google Scholar
• Rockwell, R., Des Jarlais, D. C., Friedman, S. R., Perlis, T., & Paone, D. (1999). Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care, 11, 437–442.
   PubMed Web of Science ®Google Scholar
• Ryan, C., Elliott, J., Middleton, T., Mijch, A., Street, A., Hellard, M., (2004). The molecular epidemiology of HIV type 1 among Vietnamese Australian injecting drug users in Melbourne, Australia. AIDS Research and Human Retroviruses, 20, 1364–1367.
   PubMed Web of Science ®Google Scholar
• Siddiqui, N. S., Brown, L. S., Meyer, T. J., & Gonzalez, V. (1993). Decline in HIV-1 seroprevalence and low seroconversion rate among injecting drug users at a methadone maintenance program in New York City. Journal of Psychoactive Drugs, 25, 245–250.
   PubMed Web of Science ®Google Scholar
• Spira, T., Des Jarlais, D. C., Marmor, M., Yancovitz, S., Friedman, S. R., Garber, J., (1984). Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. New England Journal of Medicine, 311, 467–468.
   Google Scholar
• Stoneburner, R., Des Jarlais, D. C., Benezra, D., Singh, T., Sotheran, J. L., Friedman, S. R., (1988). A larger spectrum of severe HIV-1-related disease in intravenous drug users in New York City. Science, 242, 916–919.
   PubMed Web of Science ®Google Scholar
• Strathdee, S. A., & Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 80, iii7–iii14.
   PubMed Web of Science ®Google Scholar
• UNAIDS/WHO. (2007). AIDS epidemic update: December 2006. Geneva: Author.
   Google Scholar
• Uuskula, A., McNutt, L., Dehovitz, J., Fischer, K., & Heimer, R. (2007). High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. International Journal of STD and AIDS, 18, 41–46.
   PubMed Web of Science ®Google Scholar
• Van Den Berg, C., Smit, C., Van Brussel, G., Coutinho, R., & Prins, M. (2007). Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction, 102, 1454–1462.
   PubMed Web of Science ®Google Scholar
• Vlahov, D., Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., (1991). The Alive Study: A longitudinal study of HIV-1 infection in intravenous drug users: Description of methods. Journal of Drug Issues, 21, 759–776.
   Web of Science ®Google Scholar
• Wood, E., Lloyd-Smith, E., Li, K., Strathdee, S., Small, W., Tyndall, M., (2007). Frequent needle exchange use and HIV incidence in Vancouver, Canada. American Journal of Medicine, 120, 172–179.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Shan, H., Trizzino, J., Ruan, Y., Beauchamp, G., Masse, B., (2007). Demographic characteristics and risk behavior associated with HIV positive injecting drug users in Xinjiang, China. Journal of Infection, 54, 285–290.
   PubMed Web of Science ®Google Scholar